or Try an Advanced Search...

    Genome Stocks List

    Symbol Grade Name % Change
    BNGO F Bionano Genomics, Inc. -0.96
    CLLS B Cellectis S.A. 17.90
    EDIT F Editas Medicine, Inc. 2.74
    ILMN D Illumina, Inc. -0.55
    OPGN F OpGen, Inc. 18.58
    PACB F Pacific Biosciences of California, Inc. 4.14
    PBE C PowerShares Dynamic Biotech & Genome 1.12
    DTIL F Precision BioSciences, Inc. 3.44
    QGEN B Qiagen N.V. -0.30
    RPTX F Repare Therapeutics Inc. 1.52
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Biology Biotechnology Acid Molecular Biology DNA Sequencing Bioinformatics CRISPR Cancer Genetic Engineering Genetics Genome Editing Genomics Lab Testing Life Sciences Polymerase Chain Reaction Scanner Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Adoptive Cell Transfer Antibiotics

    Related ETFs - A few ETFs which own one or more of the above listed Genome stocks.

    Symbol Grade Name Weight
    GNOM D Global X Genomics & Biotechnology ETF 9.51
    EKG C First Trust Nasdaq Lux Digital Health Solutions ETF 7.63
    BBH C Market Vectors Biotech ETF 6.29
    BIS C ProShares UltraShort Nasdaq Biotechnology 5.86
    EDOC D Global X Telemedicine & Digital Health ETF 4.95
    View all Genome ETFs...
    Compare ETFs
    Compare BBH to EDOC Compare BIS to EDOC Compare GNOM to EDOC

        Genome Stocks Recent News

        Date Stock Title
        May 3 ILMN Illumina, Inc. (ILMN) Q1 2024 Earnings Call Transcript
        May 2 ILMN Illumina (ILMN) Reports Q1 Earnings: What Key Metrics Have to Say
        May 2 ILMN Illumina reaffirms annual revenue forecast over continued sluggish demand
        May 2 ILMN Illumina Inc (ILMN) Q1 Earnings: Navigating Through Challenges with Mixed Results
        May 2 CLLS Cellectis announces CFO departure
        May 2 CLLS Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
        May 2 ILMN Illumina Non-GAAP EPS of $0.09 misses by $0.01, revenue of $1.08B beats by $30M
        May 2 QGEN QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications
        May 2 ILMN Illumina Reports Financial Results for First Quarter of Fiscal Year 2024
        May 2 PACB Investors Heavily Search Pacific Biosciences of California, Inc. (PACB): Here is What You Need to Know
        May 2 QGEN Qiagen N.V. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next
        May 2 EDIT Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events
        May 2 ILMN Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
        May 1 ILMN Illumina Q1 2024 Earnings Preview
        May 1 QGEN Qiagen N.V. (NYSE:QGEN) Q1 2024 Earnings Call Transcript
        May 1 EDIT Editas, Bristol Myers extend T cell therapy collaboration
        May 1 EDIT Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
        May 1 BNGO Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024
        May 1 DTIL Precision BioSciences Announces Late-Breaking Poster Presentation at the European Association for Study of the Liver (EASL) Congress 2024
        May 1 QGEN Qiagen First Quarter 2024 Earnings: EPS Beats Expectations
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Algorithms Bioinformatics Cytogenetics Genetics Genomics Informatics Maps Personal Genomics
        Genome

        In the fields of molecular biology and genetics, a genome is all genetic material of an organism. It consists of DNA (or RNA in RNA viruses). The genome includes both the genes (the coding regions) and the noncoding DNA, as well as mitochondrial DNA and chloroplast DNA. The study of the genome is called genomics.

        More about Genome
        Browse All Tags